“Drugs, like Ozempic and Wegovy, can be a game changer. I know firsthand.” – U.S. Senator John Fetterman

Recently, U.S.Senator John Fetterman has been advocating for Medicare to cover GLP-1 medications, such as Ozempic and Wegovy, which are used for diabetes and weight loss

In July, Fetterman was prescribed a drug called Mounjaro. As a stroke survivor, he was interested in studies showing it could significantly reduce the risk of major cardiac events and chronic disease.

Mounjaro is used to treat Type 2 diabetes, and a version recently received Food and Drug Administration approval for weight loss.

Even though he started taking it for his heart health, he was struck by how much better it has made him feel across the board. He stated that “it made a significant impact on his overall health. Aches, pains and stiffness have vanished. Physically, he feels a decade younger, clearer-headed and more optimistic than he’d been in years. As far as side effects, he has also lost around 20 pounds.”

And it’s not just him — millions of Americans have experienced similar life-changing benefits, regardless of why they started on these medications.

Source:  https://www.nytimes.com/2025/04/08/opinion/glp1-ozempic-mounjaro-trump.html